R.C. Jones et al. / Tetrahedron 65 (2009) 7474–7481
7479
(Oak Harbor, Washington, USA) capillary connections. Capillaries
were heated using a Waters Millipore (Billerica, Massachusetts,
USA) 112/WTC-120 temperature controlled column heater. Leading
and trailing capillary sections were used to ensure that the whole
microreactor was inside the column heater.
3.2.4. 4-Bromo-2-methylthiomethylpyridine (5)
A stirred solution of NaOMe (0.35 g, 4.97 mmol) in dry EtOH
(50 mL) was added dropwise over 10 min to a stirred solution of 4
(1.50 g, 4.52 mmol) and powdered KOH (0.76 g, 13.56 mmol) in dry
EtOH (100 mL). Stirring was continued for 12 h after which the
EtOH was removed in vacuum resulting in a pale brown oil. Water
(25 mL) was added and the product extracted with CH2Cl2
(3ꢂ25 mL). The organic phase was washed with brine and dried
over Na2SO4. The solvent was removed in vacuum to give a pale
brown oil, which was purified by column chromatography [40%
EtOAc in hexanes], to give a pale yellow oil (0.75 g, 72%). 1H NMR
3.2. Synthetic procedures
3.2.1. 4-Bromo-2-methylpyridine N-oxide (2)
Acetyl bromide (34.6 mL, 0.46 mol) was added in small portions
to a solution of 4-nitro-2-picoline N-oxide (2.47 g, 0.02 mol) in
glacial AcOH (35 mL) at 55 ꢁC. The resulting solution was heated to
120 ꢁC with stirring for 2.5 h in air. After cooling to rt the solution
was poured into crushed ice and made basic with K2CO3 and the
product extracted with CH2Cl2 (4ꢂ30 mL). The combined organic
phases were washed with brine, and dried over Na2SO4. The solvent
was removed in vacuum resulting in a pale orange oil, which was
used without further purification (2.75 g, 91%). 1H NMR (300 MHz,
(300 MHz, CDCl3):
H3), 7.34 (dd, J¼5.4, 1.8 Hz, 1H, H5), 3.76 (s, 2H, CH2), 2.06 (s, 3H,
SCH3); 13C{1H} NMR (75.4 MHz, CD3OD):
159.1 (C2), 148.6 (C6),
132.7 (C4), 125.4 (C3), 124.4 (C5), 38.5 (CH2), 14.2 (SCH3). MS (EI)
d
8.34 (d, J¼5.4 Hz, 1H, H6), 7.56 (d, J¼1.8 Hz, 1H,
d
m/z 218 [M]þ,
[ S
12C7H879Br14N32 218]. HRMS (EI) m/z [Mþ]
216.95611, [C7H8BrNS]þ requires 216.95608.
CDCl3):
d
8.11 (d, J¼6.9 Hz, 1H, H6), 7.41 (d, J¼2.4 Hz, 1H, H3), 7.27
3.2.5. 4-(4-Hydroxyphenyl)-2-methylthiomethylpyridine (6)
(dd, J¼6.9, 2.4 Hz, 1H, H5), 2.48 (s, 3H, CH3); 13C{1H} NMR
Pd(PPh3)4 (0.397 g, 5 mol %) and 5 (1.50 g, 6.88 mmol) in toluene
(28.0 mL) were treated with a degassed solution of Na2CO3 (1.60 g,
13.11 mmol, 2.2 equiv) in H2O (14.0 mL), followed by a solution of
p-HOC6H4B(OH)2 (1.42 g, 10.32 mmol) in MeOH (10.0 mL). The
resulting mixture was stirred at 95 ꢁC under Ar; after 6 h another
0.5 equiv of p-HOC6H4B(OH)2 and a further 1 mol % of catalyst was
added to the solution, and after 12 h the solution was cooled to rt
and treated with a saturated solution of Na2CO3. The product was
extracted with CH2Cl2 (3ꢂ25 mL), the organic phase was washed
with saturated NaCl solution, dried over Na2SO4 and the solvent
removed in vacuum to give a dark oil. The oil was dissolved in
CH2Cl2 (5 mL) and hexane added to precipitate a tan solid (1.56 g,
98%). The product was recrystallised from hot EtOH to give a dark
(75.4 MHz, CDCl3):
d 150.6 (C2), 140.2 (C6), 129.6 (C3), 127.0 (C5),
119.4 (C4), 17.9 (CH3). MS (EI) m/z 187 [Mþ], [12C6H679Br14N16O 187].
HRMS (EI) m/z [MꢀH]þ 186.96339, [C6H6BrNO]þ requires
186.96328.
3.2.2. 4-Bromo-2-hydroxymethylpyridine (3)
Under argon, TFAA (9.24 mL, 66.48 mmol) was added drop-
wise (with extreme caution) to
a solution of 2 (2.50 g,
13.30 mmol) in dry CH2Cl2 (40 mL) at 0 ꢁC, and the resulting so-
lution refluxed for 12 h with stirring. After cooling to rt the TFAA
and CH2Cl2 were removed in vacuum to give a dark yellow oil;
CH2Cl2 (40 mL) was added followed by 2 M NaOH with vigorous
stirring until the resulting biphasic mixture was basic (pH 12–14).
Vigorous stirring was continued for 12 h under Ar, and the mix-
ture extracted with CH2Cl2 (3ꢂ30 mL). The organic phase was
washed with brine and dried over Na2SO4. The solvent was re-
moved in vacuum resulting in a dark brown oil, which was used
without further purification. (1.55 g, 62%). 1H NMR (300 MHz,
brown solid (1.43 g, 90%). 1H NMR (300 MHz, (CD3)2CO):
d 9.01 (s,
1H, OH), 8.47 (dd, J¼5.1, 1.5 Hz, 1H, H6), 7.66 (m, 3H, H3, H4b), 7.47
(dd, J¼5.1, 1.5 Hz, 1H, H5), 6.83 (d, J¼8.7 Hz, 2H, H4c), 3.82 (s, 2H,
CH2), 2.08 (s, 3H, SCH3); 13C{1H} NMR (75.4 MHz, (CD3)2CO):
d 159.7
(C2), 158.1 (COH), 149.8 (C6), 149.7 (C4), 128.7 (C4a), 128.4 (C4b),
119.8 (C3), 119.0 (C5), 116.3 (C4c), 39.8 (CH2), 14.5 (SCH3). MS (APCI)
m/z 232 [MþH]þ, [12C13H1414N16O32S 232]. HRMS (EI) m/z [MþH]þ
232.07941, [C13H14NOS]þ requires 232.07961. Anal. Calcd for
C13H13NSO: C, 67.50; H, 5.66; N, 6.06. Found: C, 67.54; H, 5.62; N,
6.11.
CDCl3):
d
8.36 (d, J¼5.4 Hz, 1H, H6), 7.52 (dd, J¼1.8 Hz, 1H, H3),
7.39 (dd, J¼5.4, 1.8 Hz, 1H, H5), 4.75 (s, 2H, CH2), 4.16 (s, 1H, OH);
13C{1H} NMR (75.4 MHz, CDCl3):
d 161.1 (C2), 149.2 (C6), 134.1
(C4), 126.0 (C5), 124.3 (C3), 63.9 (CH2). MS (EI) m/z 187 [MꢀH]þ,
[
12C6H579Br14N16
O
186]. HRMS (EI) m/z [MꢀHþ] 185.95554,
[C6H5BrNO]þ requires 185.95545.
3.2.6. 4-(4-Benzyloxy)-2-methylthiomethylpyridine (7)
This compound was prepared from 5 (1.50 g, 6.88 mmol) and
4-BnOC6H4B(OH)2 (2.35 g, 10.32 mmol) using a similar procedure
to that described for 6. The product was purified by column
chromatography (40% EtOAc in hexanes) to remove contamination
by BnOPh to give a pale yellow oil (1.88 g, 85%). 1H NMR (300 MHz,
3.2.3. 4-Bromo-2-bromomethylpyridine hydrobromide (4)
PBr3 (5.55 mL, 59.03 mmol) was added dropwise (with extreme
caution) to a solution of 3 (1.85 g, 9.84 mmol) in dry CHCl3 (50 mL)
at 0 ꢁC, and the resulting solution was heated to reflux for 12 h with
vigorous stirring. After cooling to rt the suspension was poured into
crushed ice and made basic (pHw14) with K2CO3, and the product
was extracted with CH2Cl2 (4ꢂ50 mL). The organic phase was
washed with brine and dried over Na2SO4. The solvent was re-
moved in vacuum, and the resulting pale brown oil was then dis-
solved in Et2O and with vigorous stirring; HBr/AcOH solution was
added dropwise to precipitate an off white solid, which was col-
lected by filtration and washed thoroughly with Et2O (2.84 g, 87%).
Single crystals for X-ray and elemental analysis were grown from
vapour diffusion of Et2O into MeNO2. 1H NMR (300 MHz, CD3OD):
(CD3)2SO):
d
8.53 (d, J¼5.4 Hz, 1H, H6), 7.76 (dd, J¼5.4, 1.8 Hz, 1H,
H5), 7.60 (d, J¼8.7 Hz, 2H, H4b), 7.56 (d, J¼1.8 Hz, 1H, H3), 7.46–
7.34 (m, 5H, H4b2, H4c2, H4d2), 7.07 (d, J¼8.7 Hz, 1H, H4c), 5.12 (s,
2H, OCH2), 3.86 (s, 2H, SCH2), 2.10 (s, 3H, SCH3); 13C{1H} NMR
(75.4 MHz, (CD3)2SO):
d 160.1 (C2), 158.9 (C4d), 149.4 (C6), 149.1
(C4), 136.8 (C4a2), 128.9 (C4b), 128.6 (C4c2), 128.4 (C4d2), 127.7
(C4b2), 120.7 (C5), 119.8 (C3), 115.7 (C4c), 70.0 (OCH2), 40.0 (SCH2),
22.9 (SCH3). MS (EI) m/z 321 [M]þ, [12C20H1914N16O32S 321]. HRMS
(EI) m/z [Mþ] 321.11868, [C20H19NOS]þ requires 321.11873. Anal.
Calcd for C13H13NSO: C, 67.50; H, 5.66; N, 6.06. Found: C, 67.54; H,
5.62; N, 6.11.
d
8.70 (d, J¼6.3 Hz, 1H, H6), 8.42 (d, J¼2.1 Hz, 1H, H3), 8.21 (dd,
J¼6.3, 2.1 Hz, 1H, H5), 4.81 (s, 2H, CH2); 13C{1H} NMR (75.4 MHz,
CD3OD):
d
153.4 (C2), 144.1 (C4), 143.7 (C6), 130.9 (C5), 130.1 (C3),
3.2.7. Dichloro{4-(4-hydroxyphenyl)-2-methylthiomethyl-
pyridine}palladium(II) (8)
PdCl2(NCMe)2 (0.15 g, 0.64 mmol) was added to a stirred sus-
pension of 6 (0.18 g, 0.77 mmol) in dry MeCN (30 mL) and the
brown suspension was stirred for 12 h at 50 ꢁC. The solvent was
24.8 (CH2). MS (EI) m/z 251 [MꢀHBr]þ, [12C6H579Br214N 251]. HRMS
(EI) m/z [MꢀHBr]þ 248.87875, [C6H5Br2N]þ requires 248.87887.
Anal. Calcd for C6H6Br2N: C, 21.72; H, 1.82; N, 4.22. Found: C, 22.12;
H, 1.78; N, 4.20.